Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds

Código 2934 (Harmonized System 2012 by 4 digits)

 2020: US$426M, Total Trade Exchange

2020: US$195M, International Sales

  2020: US$231M, International Purchases

In 2020, the trade exchange (includes international purchases and sales) of Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds was US$426M.

In 2020, the states with the most international sales in Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds were Nuevo León (US$116M), Ciudad de México (US$39.4M), Estado de México (US$21M), Morelos (US$13.2M), and Querétaro (US$4.24M).

The states with the most international purchases in 2020 were Ciudad de México (US$72.6M), Nuevo León (US$61.2M), Estado de México (US$35.7M), Coahuila de Zaragoza (US$30.5M), and Jalisco (US$14.1M).

In 2020, the main commercial destinations of Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds were United States (US$110M), India (US$21.6M), Brazil (US$13.8M), Canada (US$8.18M), and Spain (US$6.91M).

The main commercial origins of Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds in 2020 were China (US$124M), India (US$33.9M), Switzerland (US$15.9M), Spain (US$11.2M), and Germany (US$9.32M).

In the global context, the main exporting countries of Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds in 2019 were Ireland (US$4.2B), China (US$3.27B), and Switzerland (US$1.9B). In the same year, the main importing countries of Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds were United States (US$6.37B), Germany (US$1.71B), and Japan (US$1.58B).

Trade Balance of Mexico

#permalink to section

Net Trade Balance

#permalink to section
info-sign

US$426M, Total Trade Exchange (2020)

In 2020, the total trade exchange of Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds in Mexico (including international purchases and sales) was US$426M.

The visualizations show the net balance of Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.

Net International Trade

#permalink to section
info-sign

October, 2021

  • US$21.5M, International Purchases
  • US$11.4M, International Sales

In October 2021, international sales of Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds were US$11.4M, while international purchases reached US$21.5M. The above results in a trade balance of -US$10.1M.

Market Concentration

#permalink to section

2021-Q4: US$3.47M, International Sales

The visualization shows the quarterly concentration of international sales of Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds at state level.

In the fourth quarter of 2021, international sales were US$3.47M, being the states with the most sales Ciudad de México (US$1.81M) and Estado de México (US$1.66M).

Exchange by Territory

#permalink to section

International Sales

#permalink to section
info-sign

Nuevo León: US$116M, State with the Most International Sales (2020)

United States: US$110M, Main commercial destination (2020)

In 2020, the states with the highest international sales in Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds were Nuevo León (US$116M), Ciudad de México (US$39.4M), Estado de México (US$21M), Morelos (US$13.2M), and Querétaro (US$4.24M).

In 2020, the countries with the most international purchases from Mexico were United States (US$110M), India (US$21.6M), Brazil (US$13.8M), Canada (US$8.18M), and Spain (US$6.91M).

International Purchases

#permalink to section
info-sign

Ciudad de México: US$72.6M, State with the Most International Purchases (2020)

China: US$124M, Main Commercial Origin (2020)

In 2020, the states with the highest international in Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds were Ciudad de México (US$72.6M), Nuevo León (US$61.2M), Estado de México (US$35.7M), Coahuila de Zaragoza (US$30.5M), and Jalisco (US$14.1M).

The countries with the most international sales to Mexico in 2020 were China (US$124M), India (US$33.9M), Switzerland (US$15.9M), Spain (US$11.2M), and Germany (US$9.32M).

Specialization

#permalink to section

Specialization by State

#permalink to section

The RCA-Complexity  diagram compares the Revelead Comparative Advantages of states in Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds  and the Economic Complexity Index of each state.

RCA values ​​greater than 1 indicate that the state has comparative advantages in Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.

Origins and Trade Destinations

#permalink to section

  • 0.68%, Mexican share in global exports - 2019
  • 1.15%, Mexican share in global imports - 2019

The visualizations show the global market for Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds. In both charts, Mexico stands out in order to identify its participation in the export and import market.

In 2019, the main exporting countries of Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds were Ireland (US$4.2B), China (US$3.27B), and Switzerland (US$1.9B). In the same year, the main importing countries for Nucleic Acids and their Salts, whether or not Chemically no Definite Constitution; others Heterocyclic Compounds were United States (US$6.37B), Germany (US$1.71B), and Japan (US$1.58B).